Evidence map›Paper›PMID 41803895›Full record

ArticleClinical epigenetics2026

The m

Shichong Jia, Ludi Yang, Pinghui Wei, Jie Yu, Guoge Han, Yan Wang

Abstract read
In one paragraph

Article in Clinical epigenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. NSUN2-Mediated mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shichong Jia *Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Institute, Nankai University Affiliated Eye Hospital, Tianjin, China.
Ludi Yang *Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pinghui Wei *Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Institute, Nankai University Affiliated Eye Hospital, Tianjin, China.
Jie YuDepartment of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. yujiehzxs@163.com.
Guoge HanTianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Institute, Nankai University Affiliated Eye Hospital, Tianjin, China. dovehanguoge@hotmail.com.
Yan WangTianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Institute, Nankai University Affiliated Eye Hospital, Tianjin, China. wangyan7143@vip.sina.com.

Funding

Nankai University Eye Institute NKYKK202305National Natural Science Foundation of China 12505410National Natural Science Foundation of China 82271118National Natural Science Foundation of China 82301240National Natural Science Foundation of China 82303106the National Program on Key Research Project of China 2022YFC2404502
6 · The paper itself

Abstract

backgroundThe global prevalence of myopia has risen sharply, particularly among children and adolescents in urban and highly educated populations. RNA modifications have been recognized as important regulators in myopia progression. However, the role of m

methodsKey RNA modification-related genes were first identified through weighted gene co-expression network analysis (WGCNA), based on expression profiles of m

resultsUtilizing WGCNA, we identified Tet1, an m

conclusionOur study reveals substantial alterations in TET1 expression and m

Indexed as

Mixed Function OxygenasesMyopiaProto-Oncogene ProteinsScleraAnimalsApoptosisCell ProliferationFemaleFibroblastsGene Expression ProfilingHumansMaleMiceRNA MethylationMixed Function OxygenasesProto-Oncogene ProteinsTET1 protein, humanHypoxiam5C modificationMyopiaRNA modificationScleraTET1

Identifiers

PMID41803895
PMCPMC13085550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.